Skip to Main Content

Neurodementias

Filter by

Solution
NeuroAlign CT NeuroQuant NeuroQuant ARIA NeuroQuant Brain Tumor NeuroQuant MS NeuroQuant PET OnQ Prostate
Topic
Case studies Cortechs.ai news Industry news Product updates Published research Whitepapers
Disease
ADHD Alzheimer's disease Brain cancer COVID-19 Epilepsy Mild cognitive impairment Multiple sclerosis Neurodementias Prostate cancer PTSD Traumatic brain injury

Clear all filters

2 mins

Mar 18 2020

Predicting progression of MCI

The NeuroQuant® Dementia report includes important biomarkers used to predict progression of mild cognitive impairment to Alzheimer's disease.

Case studies

2 mins

Jun 20 2016

Customer Spotlight: NeuroQuant – Changing Approach to Patients with Memory Loss

Read more about Customer Spotlight: NeuroQuant – Changing Approach to Patients with Memory Loss

Case studies

2 mins

Feb 24 2016

Understanding the Hippocampal Occupancy Score

Read more about Understanding the Hippocampal Occupancy Score

Case studies

2 mins

Feb 6 2016

The Science Behind NeuroQuant: Biomarkers in Early Detection and Evaluation of Neurodegeneration

Read more about The Science Behind NeuroQuant: Biomarkers in Early Detection and Evaluation of Neurodegeneration

Product updates

Our solutions

Advanced AI tools tailored for improved disease prediction and monitoring.

View all solutions

AI radiology news

Stay up to date with the latest insights, advances and clinical applications

Subscribe

"NeuroQuant® is the clinical gold standard for MRI brain volume measurement."

Dr David E. Ross

Director, Virginia Institute of Neuropsychiatry

"Utilizing NeuroQuant® in our health system has provided invaluable information which leads to improved patient care."

Dr. Ana Franceschi

Associate Professor, Radiology, Zucker School of Medicine